Centene downgraded its 2024 adjusted earnings per share target this week to greater than $6.60, reflecting its view of Medicaid redeterminations, its Medicare bid strategy and business investments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback